# Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy Volunteers

> **NCT02325713** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oral dispersible tablet of praziquantel (ODT-PZQ)
- **DRUG:** Cysticide
- **DRUG:** ODT-PZQ
- **DRUG:** ODT-PZQ
- **DRUG:** ODT-PZQ
- **DRUG:** Cysticide

## Key facts

- **NCT ID:** NCT02325713
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325713, "Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02325713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*